Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study.

Int J Cardiol Heart Vasc · 2019 · PMC6510975 · PMID 31111087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Overall, the results showed a trend towards a reduced incidence and related risk of stroke and ICH associated with rivaroxaban use compared with phenprocoumon.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.